Biomarker Evidence of Axonal Injury in Neuroasymptomatic HIV-1 Patients
Jan Jessen Krut(University of Gothenburg), Magnus Gisslén(Public Health Agency of Sweden), Lars Rosengren(Sahlgrenska University Hospital), Tomas Mellberg(Sahlgrenska University Hospital), Richard W. Price(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Henrik Zetterberg(University of Wisconsin–Madison), Lars Hagberg(Sahlgrenska University Hospital), Dietmar Fuchs(Innsbruck Medical University), Staffan Nilsson(Chalmers University of Technology)
Cited by 167
Related Papers
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k
Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.
|The Journal of Experimental Medicine|1984|1.1k
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
|JAMA Neurology|2021|627
Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report
|Nature Medicine|2019|606
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease
|Alzheimer s & Dementia|2022|589